PDE-4 Inhibitor Roflumilast and Polycystic Ovary Syndrome
- Status
- COMPLETED
- Phase
- PHASE4
Clinical Trials Related to Metformin
Related studies linked through entity extraction aliases.
Safety and Efficacy of Ertugliflozin in the Treatment of Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin and Sitagliptin (MK-8835-006; VERTIS SITA2)
- Status
- COMPLETED
- Phase
- PHASE3
Metformin With the Levonorgestrel-Releasing Intrauterine Device for the Treatment of Complex Atypical Hyperplasia (CAH) and Endometrial Cancer (EC) in Non-surgical Patients
- Status
- COMPLETED
- Phase
- PHASE2
A Study To Evaluate The Efficacy And Safety Of Ertugliflozin In Participants With Type 2 Diabetes Mellitus And Inadequate Glycemic Control On Metformin Monotherapy (MK-8835-007).
- Status
- COMPLETED
- Phase
- PHASE3
Phase II Study of Metformin for Reduction of Obesity-Associated Breast Cancer Risk
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy and Safety of Insulin Glargine in Patients With Type 2 Diabetes With Inadequate Control on DPP-4 Inhibitor Therapy
- Status
- COMPLETED
- Phase
- PHASE4
Metformin and Pioglitazone Effects on Fetuin-A and Osteoprotegrin Concentrations in Type 2 Diabetes Patients
- Status
- COMPLETED
- Phase
- NA
Vaginal Administration of Metformin in PCOS Patients.
- Status
- UNKNOWN
- Phase
- EARLY_PHASE1
Influence of Semaglutide on Pharmacokinetics and Pharmacodynamics of Warfarin and Pharmacokinetics of Metformin in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
A Study of the Safety and Effectiveness of LY3053102 in Participants With Type 2 Diabetes
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Metformin and Carbohydrate Restriction With Platinum Based Chemotherapy In Stage IIIB/IV Non-Squamous Non-Small Cell Lung Cancer (NS-NSCLC)
- Status
- TERMINATED
- Phase
- PHASE2
Metformin in the Diastolic Dysfunction of Metabolic Syndrome
- Status
- COMPLETED
- Phase
- PHASE2
Effect of Liraglutide on Epicardial Fat in Subjects With Type 2 Diabetes
- Status
- COMPLETED
- Phase
- PHASE4
Glycemic Excursions in Type 2 Diabetic Patients With Vildagliptin and Metformin Versus Vildagliptin and Glimepiride
- Status
- COMPLETED
- Phase
- PHASE4
Metformin Combined With Gemcitabine as Adjuvant Therapy for Pancreatic Cancer After Curative Resection
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Assess the Safety, Tolerability and Glucose-Lowering Efficacy of MK-0893 in Participants With Type 2 Diabetes Mellitus (MK-0893-005)
- Status
- COMPLETED
- Phase
- PHASE2
Study of Efficacy and Safety of Vildagliptin as add-on Insulin Therapy in T2DM Patients
- Status
- COMPLETED
- Phase
- PHASE4
Ertugliflozin vs. Glimepiride in Type 2 Diabetes Mellitus (T2DM) Participants on Metformin (MK-8835-002)
- Status
- COMPLETED
- Phase
- PHASE3
Metformin in Stage IV Lung Adenocarcinoma
- Status
- TERMINATED
- Phase
- PHASE2
Prevention of Metabolic Syndrome and Increased Weight Using Metformin Concurrent to Androgen Deprivation Therapy and Radiotherapy for Locally Advanced Adenocarcinoma of the Prostate
- Status
- TERMINATED
- Phase
- PHASE2